3CN1 image
Entry Detail
PDB ID:
3CN1
Title:
Human transthyretin (TTR) in complex with 3,5-Dibromo-4-hydroxystilbene
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2008-03-24
Release Date:
2008-10-28
Method Details:
Experimental Method:
Resolution:
1.52 Å
R-Value Free:
0.18
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Transthyretin
Chain IDs:A, B
Chain Length:127
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Toward optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.
J.Med.Chem. 51 6348 6358 (2008)
PMID: 18811132 DOI: 10.1021/jm800435s

Abstact

To develop potent and highly selective transthyretin (TTR) amyloidogenesis inhibitors, it is useful to systematically optimize the three substructural elements that compose a typical TTR kinetic stabilizer: the two aryl rings and the linker joining them. Herein, we evaluated 40 bisaryl molecules based on 10 unique linker substructures to determine how these linkages influence inhibitor potency and selectivity. These linkers connect one unsubstituted aromatic ring to either a 3,5-X 2 or a 3,5-X 2-4-OH phenyl substructure (X = Br or CH 3). Coconsideration of amyloid inhibition and ex vivo plasma TTR binding selectivity data reveal that direct connection of the two aryls or linkage through nonpolar E-olefin or -CH 2CH 2- substructures generates the most potent and selective TTR amyloidogenesis inhibitors exhibiting minimal undesirable binding to the thyroid hormone nuclear receptor or the COX-1 enzyme. Five high-resolution TTR.inhibitor crystal structures (1.4-1.8 A) provide insight into why such linkers afford inhibitors with greater potency and selectivity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures